НОВАЯ СТАТЬЯ
Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis.
Myelofibrosis (MF) is a myeloproliferative neoplasm characterized by marrow fibrosis, splenomegaly, constitutional symptoms and cytopenia with a proinflammatory and profibrotic cytokine phenotype involving the JAK-STAT pathway...